1H MR spectroscopy of the basal ganglia in childhood: A semiquantitative analysis

W. W M Lam, Z. J. Wang, H. Zhao, G. T. Berry, P. Kaplan, J. Gibson, B. S. Kaplan, L. T. Bilaniuk, J. V. Hunter, J. C. Haselgrove, R. A. Zimmermann

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Proton MR spectra of the basal ganglia were obtained from 28 patients, 24 male and 14 female, median age 16.3 months (5 weeks to 31 years). They included 17 patients with normal MRI of the basal ganglia without metabolic disturbance (control group) and 11 patients with various metabolic diseases: one case each of high serum sodium and high serum osmolarity, cobalamin C deficiency, Leigh disease, Galloway-Mowat syndrome, Pelizaeus-Merz bacher disease, hemolytic-uremic syndrome and Wilson disease and two cases of Alagille syndrome and methylmalonic acidemia with abnormal MRI of the basal ganglia or blood or urine analysis (abnormal group). The MR spectrum was measured by using STEAM. The MR visible water content of the region of interest was obtained. Levels of myoinositol, choline, creatine and N-acetylaspartate were measured using a semiquantitative approach, with absolute reference calibration. In the control group, there was a gradual drop of water content over the first year of life; N-acetylaspartate, creatine and myoinositol levels showed no significant change with age, in contrast to the occipital, parietal and cerebellar regions. Choline showed a gradual decrease for the first 2 years of life and then remained fairly constant. In the abnormal group the water content was not significantly different, N-Acetylaspartate was decreased in patients with high serum sodium and high serum osmolarity, cobalamin C deficiency, Leigh disease and one case of methylmalonic acidemia. Decreased creatine was also found in Leigh disease, and decreased choline in Galloway-Mowat syndrome and Wilson disease. Myoinositol was elevated in the patient with abnormally high serum sodium, and decreased in the hemolytic-uremic syndrome.

Original languageEnglish (US)
Pages (from-to)315-323
Number of pages9
JournalNeuroradiology
Volume40
Issue number5
DOIs
StatePublished - 1998

Fingerprint

Basal Ganglia
Leigh Disease
Magnetic Resonance Spectroscopy
Creatine
Inositol
Choline
Deficiency Diseases
Serum
Hepatolenticular Degeneration
Hemolytic-Uremic Syndrome
Sodium
Vitamin B 12
Osmolar Concentration
Water
Alagille Syndrome
Control Groups
Parietal Lobe
Metabolic Diseases
Calibration
Protons

Keywords

  • Basal ganglia
  • Childhood
  • Magnetic resonance spectroscopy
  • Metabolic disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Lam, W. W. M., Wang, Z. J., Zhao, H., Berry, G. T., Kaplan, P., Gibson, J., ... Zimmermann, R. A. (1998). 1H MR spectroscopy of the basal ganglia in childhood: A semiquantitative analysis. Neuroradiology, 40(5), 315-323. https://doi.org/10.1007/s002340050592

1H MR spectroscopy of the basal ganglia in childhood : A semiquantitative analysis. / Lam, W. W M; Wang, Z. J.; Zhao, H.; Berry, G. T.; Kaplan, P.; Gibson, J.; Kaplan, B. S.; Bilaniuk, L. T.; Hunter, J. V.; Haselgrove, J. C.; Zimmermann, R. A.

In: Neuroradiology, Vol. 40, No. 5, 1998, p. 315-323.

Research output: Contribution to journalArticle

Lam, WWM, Wang, ZJ, Zhao, H, Berry, GT, Kaplan, P, Gibson, J, Kaplan, BS, Bilaniuk, LT, Hunter, JV, Haselgrove, JC & Zimmermann, RA 1998, '1H MR spectroscopy of the basal ganglia in childhood: A semiquantitative analysis', Neuroradiology, vol. 40, no. 5, pp. 315-323. https://doi.org/10.1007/s002340050592
Lam, W. W M ; Wang, Z. J. ; Zhao, H. ; Berry, G. T. ; Kaplan, P. ; Gibson, J. ; Kaplan, B. S. ; Bilaniuk, L. T. ; Hunter, J. V. ; Haselgrove, J. C. ; Zimmermann, R. A. / 1H MR spectroscopy of the basal ganglia in childhood : A semiquantitative analysis. In: Neuroradiology. 1998 ; Vol. 40, No. 5. pp. 315-323.
@article{b710cbc56caf48d78587d59dab37baea,
title = "1H MR spectroscopy of the basal ganglia in childhood: A semiquantitative analysis",
abstract = "Proton MR spectra of the basal ganglia were obtained from 28 patients, 24 male and 14 female, median age 16.3 months (5 weeks to 31 years). They included 17 patients with normal MRI of the basal ganglia without metabolic disturbance (control group) and 11 patients with various metabolic diseases: one case each of high serum sodium and high serum osmolarity, cobalamin C deficiency, Leigh disease, Galloway-Mowat syndrome, Pelizaeus-Merz bacher disease, hemolytic-uremic syndrome and Wilson disease and two cases of Alagille syndrome and methylmalonic acidemia with abnormal MRI of the basal ganglia or blood or urine analysis (abnormal group). The MR spectrum was measured by using STEAM. The MR visible water content of the region of interest was obtained. Levels of myoinositol, choline, creatine and N-acetylaspartate were measured using a semiquantitative approach, with absolute reference calibration. In the control group, there was a gradual drop of water content over the first year of life; N-acetylaspartate, creatine and myoinositol levels showed no significant change with age, in contrast to the occipital, parietal and cerebellar regions. Choline showed a gradual decrease for the first 2 years of life and then remained fairly constant. In the abnormal group the water content was not significantly different, N-Acetylaspartate was decreased in patients with high serum sodium and high serum osmolarity, cobalamin C deficiency, Leigh disease and one case of methylmalonic acidemia. Decreased creatine was also found in Leigh disease, and decreased choline in Galloway-Mowat syndrome and Wilson disease. Myoinositol was elevated in the patient with abnormally high serum sodium, and decreased in the hemolytic-uremic syndrome.",
keywords = "Basal ganglia, Childhood, Magnetic resonance spectroscopy, Metabolic disease",
author = "Lam, {W. W M} and Wang, {Z. J.} and H. Zhao and Berry, {G. T.} and P. Kaplan and J. Gibson and Kaplan, {B. S.} and Bilaniuk, {L. T.} and Hunter, {J. V.} and Haselgrove, {J. C.} and Zimmermann, {R. A.}",
year = "1998",
doi = "10.1007/s002340050592",
language = "English (US)",
volume = "40",
pages = "315--323",
journal = "Neuroradiology",
issn = "0028-3940",
publisher = "Springer Verlag",
number = "5",

}

TY - JOUR

T1 - 1H MR spectroscopy of the basal ganglia in childhood

T2 - A semiquantitative analysis

AU - Lam, W. W M

AU - Wang, Z. J.

AU - Zhao, H.

AU - Berry, G. T.

AU - Kaplan, P.

AU - Gibson, J.

AU - Kaplan, B. S.

AU - Bilaniuk, L. T.

AU - Hunter, J. V.

AU - Haselgrove, J. C.

AU - Zimmermann, R. A.

PY - 1998

Y1 - 1998

N2 - Proton MR spectra of the basal ganglia were obtained from 28 patients, 24 male and 14 female, median age 16.3 months (5 weeks to 31 years). They included 17 patients with normal MRI of the basal ganglia without metabolic disturbance (control group) and 11 patients with various metabolic diseases: one case each of high serum sodium and high serum osmolarity, cobalamin C deficiency, Leigh disease, Galloway-Mowat syndrome, Pelizaeus-Merz bacher disease, hemolytic-uremic syndrome and Wilson disease and two cases of Alagille syndrome and methylmalonic acidemia with abnormal MRI of the basal ganglia or blood or urine analysis (abnormal group). The MR spectrum was measured by using STEAM. The MR visible water content of the region of interest was obtained. Levels of myoinositol, choline, creatine and N-acetylaspartate were measured using a semiquantitative approach, with absolute reference calibration. In the control group, there was a gradual drop of water content over the first year of life; N-acetylaspartate, creatine and myoinositol levels showed no significant change with age, in contrast to the occipital, parietal and cerebellar regions. Choline showed a gradual decrease for the first 2 years of life and then remained fairly constant. In the abnormal group the water content was not significantly different, N-Acetylaspartate was decreased in patients with high serum sodium and high serum osmolarity, cobalamin C deficiency, Leigh disease and one case of methylmalonic acidemia. Decreased creatine was also found in Leigh disease, and decreased choline in Galloway-Mowat syndrome and Wilson disease. Myoinositol was elevated in the patient with abnormally high serum sodium, and decreased in the hemolytic-uremic syndrome.

AB - Proton MR spectra of the basal ganglia were obtained from 28 patients, 24 male and 14 female, median age 16.3 months (5 weeks to 31 years). They included 17 patients with normal MRI of the basal ganglia without metabolic disturbance (control group) and 11 patients with various metabolic diseases: one case each of high serum sodium and high serum osmolarity, cobalamin C deficiency, Leigh disease, Galloway-Mowat syndrome, Pelizaeus-Merz bacher disease, hemolytic-uremic syndrome and Wilson disease and two cases of Alagille syndrome and methylmalonic acidemia with abnormal MRI of the basal ganglia or blood or urine analysis (abnormal group). The MR spectrum was measured by using STEAM. The MR visible water content of the region of interest was obtained. Levels of myoinositol, choline, creatine and N-acetylaspartate were measured using a semiquantitative approach, with absolute reference calibration. In the control group, there was a gradual drop of water content over the first year of life; N-acetylaspartate, creatine and myoinositol levels showed no significant change with age, in contrast to the occipital, parietal and cerebellar regions. Choline showed a gradual decrease for the first 2 years of life and then remained fairly constant. In the abnormal group the water content was not significantly different, N-Acetylaspartate was decreased in patients with high serum sodium and high serum osmolarity, cobalamin C deficiency, Leigh disease and one case of methylmalonic acidemia. Decreased creatine was also found in Leigh disease, and decreased choline in Galloway-Mowat syndrome and Wilson disease. Myoinositol was elevated in the patient with abnormally high serum sodium, and decreased in the hemolytic-uremic syndrome.

KW - Basal ganglia

KW - Childhood

KW - Magnetic resonance spectroscopy

KW - Metabolic disease

UR - http://www.scopus.com/inward/record.url?scp=0031595484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031595484&partnerID=8YFLogxK

U2 - 10.1007/s002340050592

DO - 10.1007/s002340050592

M3 - Article

C2 - 9638674

AN - SCOPUS:0031595484

VL - 40

SP - 315

EP - 323

JO - Neuroradiology

JF - Neuroradiology

SN - 0028-3940

IS - 5

ER -